sample_id;sample;participant_id;age;sex;day;condition;gse_id;vaccine;week;dose;infection;type;regimen;disease_vac;severity;variant;prior_infection;previous_vaccination;country;enroll_time;sequencer
GSM6066090;Naive_17_Day0;Naive_17;58;Male;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066091;Naive_18_Day0;Naive_18;56;Female;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066092;Naive_24_Day0;Naive_24;37;Female;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066093;Naive_26_Day0;Naive_26;19;Female;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066094;Naive_27_Day0;Naive_27;31;Female;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066095;Naive_28_Day0;Naive_28;36;Male;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066096;Naive_29_Day0;Naive_29;21;Female;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066097;Naive_30_Day0;Naive_30;23;Female;0;H (D0);GSE201530;H;0;0;0;H;H;H;H;None;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066114;Omicron_17_1st;Omicron_17;83;Male;1;I (D1);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066118;Omicron_24_1st;Omicron_24;51;Female;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066119;Omicron_25_1st;Omicron_25;54;Male;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066120;Omicron_26_1st;Omicron_26;83;Female;0;I (D0);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066121;Omicron_27_1st;Omicron_27;32;Female;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066122;Omicron_28_1st;Omicron_28;36;Male;3;I (D3);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066123;Omicron_29_1st;Omicron_29;30;Female;4;I (D4);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066124;Omicron_30_1st;Omicron_30;28;Female;1;I (D1);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066125;Omicron_31_1st;Omicron_31;29;Male;1;I (D1);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066126;Omicron_33_1st;Omicron_33;61;Male;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066127;Omicron_34_1st;Omicron_34;59;Female;0;I (D0);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066130;Omicron_38_1st;Omicron_38;62;Female;4;I (D4);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066133;Omicron_48_1st;Omicron_48;32;Female;1;I (D1);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066134;Omicron_49_1st;Omicron_49;35;Female;0;I (D0);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066135;Omicron_50_1st;Omicron_50;38;Female;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066138;Omicron_53_1st;Omicron_53;40;Female;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066139;Omicron_55_1st;Omicron_55;61;Female;2;I (D2);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066141;Omicron_66_1st;Omicron_66;39;Female;0;I (D0);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066142;Omicron_67_1st;Omicron_67;39;Female;3;I (D3);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066143;Omicron_68_1st;Omicron_68;40;Female;3;I (D3);GSE201530;I;1;0;1;I;I;I;MI;Omicron;No;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066110;Omicron_13_1st;Omicron_13;39;Male;2;I-I (D2);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066128;Omicron_35_1st;Omicron_35;54;Female;5;I-I (D5);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066129;Omicron_37_1st;Omicron_37;63;Male;5;I-I (D5);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066131;Omicron_42_1st;Omicron_42;26;Male;3;I-I (D3);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066132;Omicron_43_1st;Omicron_43;24;Female;0;I-I (D0);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066136;Omicron_51_1st;Omicron_51;37;Female;1;I-I (D1);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066144;Omicron_70_1st;Omicron_70;28;Male;2;I-I (D2);GSE201530;I;1;0;2;I;I-I;I;MI;Omicron;Yes;No;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066137;Omicron_52_1st;Omicron_52;24;Female;5;I-BNT (D5);GSE201530;BNT;1;1;2;RNA;I-V;I;MI;Omicron;Yes;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066098;Omicron_1_1st;Omicron_1;50;Male;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066099;Omicron_2_1st;Omicron_2;36;Male;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066100;Omicron_3_1st;Omicron_3;30;Female;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066101;Omicron_4_1st;Omicron_4;17;Female;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066102;Omicron_5_1st;Omicron_5;20;Male;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066103;Omicron_6_1st;Omicron_6;57;Male;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066104;Omicron_7_1st;Omicron_7;30;Male;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066105;Omicron_8_1st;Omicron_8;21;Female;2;BNT-I (D2);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066106;Omicron_9_1st;Omicron_9;23;Male;3;BNT-I (D3);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066107;Omicron_10_1st;Omicron_10;27;Female;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066108;Omicron_11_1st;Omicron_11;80;Female;0;BNT-I (D0);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066109;Omicron_12_1st;Omicron_12;38;Female;3;BNT-I (D3);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066111;Omicron_14_1st;Omicron_14;29;Female;2;BNT-I (D2);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066112;Omicron_15_1st;Omicron_15;55;Female;3;BNT-I (D3);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066113;Omicron_16_1st;Omicron_16;26;Male;2;BNT-I (D2);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066115;Omicron_18_1st;Omicron_18;23;Female;2;BNT-I (D2);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066116;Omicron_19_1st;Omicron_19;20;Female;2;BNT-I (D2);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066117;Omicron_20_1st;Omicron_20;82;Male;1;BNT-I (D1);GSE201530;BNT;1;2;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000
GSM6066140;Omicron_65_1st;Omicron_65;42;Female;1;BNT-I (D1);GSE201530;BNT;1;1;1;RNA;V-V-I;I;MI;Omicron;No;Yes;Korea;December 2021 and March 2022;Illumina NovaSeq 6000